Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience

ANDREA SBRANA, ELISA BIASCO, FEDERICO PAOLIERI, ERICA PALESANDRO, CLAUDIA CASERTA, ROBERTO IACOVELLI, BEATRICE DETTI, DANIELE SANTINI, ALESSANDRA MOSCA, FRANCO MORELLI, GIUSEPPE FORNARINI, UGO DE GIORGI, CRISTINA MASINI and LUCA GALLI
Anticancer Research August 2018, 38 (8) 4913-4918; DOI: https://doi.org/10.21873/anticanres.12807
ANDREA SBRANA
1U.O. Oncologia Medica 2 Universitaria, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andreasbrana89@gmail.com
ELISA BIASCO
2DH Oncologico Portoferraio, Azienda Toscana Nord Ovest, Livorno, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FEDERICO PAOLIERI
1U.O. Oncologia Medica 2 Universitaria, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERICA PALESANDRO
3Istituto di Candiolo – IRCCS, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLAUDIA CASERTA
4S. C. Oncologia Medica, Azienda Ospedaliera S. Maria, Terni, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERTO IACOVELLI
5U.O.C. Oncologia Medica, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BEATRICE DETTI
6U.O. Radioterapia, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIELE SANTINI
7U.O.S. Day Hospital di Oncologia, Università Campus Biomedico, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALESSANDRA MOSCA
8S.C. Oncologia Medica, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCO MORELLI
9U.O.C. Oncologia, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GIUSEPPE FORNARINI
10U.O. Oncologia Medica 1, Policlinico San Martino, Genoa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
UGO DE GIORGI
11U.O. Oncologia Medica, IRST, Meldola, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CRISTINA MASINI
12U.O. Oncologia Medica, Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LUCA GALLI
1U.O. Oncologia Medica 2 Universitaria, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 38 no. 8 4913-4918
DOI 
https://doi.org/10.21873/anticanres.12807
PubMed 
30061269

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 22, 2018
  • Revision received June 11, 2018
  • Accepted June 12, 2018
  • Published online July 30, 2018.

Copyright & Usage 
Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. ANDREA SBRANA1⇑,
  2. ELISA BIASCO2,
  3. FEDERICO PAOLIERI1,
  4. ERICA PALESANDRO3,
  5. CLAUDIA CASERTA4,
  6. ROBERTO IACOVELLI5,
  7. BEATRICE DETTI6,
  8. DANIELE SANTINI7,
  9. ALESSANDRA MOSCA8,
  10. FRANCO MORELLI9,
  11. GIUSEPPE FORNARINI10,
  12. UGO DE GIORGI11,
  13. CRISTINA MASINI12 and
  14. LUCA GALLI1
  1. 1U.O. Oncologia Medica 2 Universitaria, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
  2. 2DH Oncologico Portoferraio, Azienda Toscana Nord Ovest, Livorno, Italy
  3. 3Istituto di Candiolo – IRCCS, Turin, Italy
  4. 4S. C. Oncologia Medica, Azienda Ospedaliera S. Maria, Terni, Italy
  5. 5U.O.C. Oncologia Medica, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy
  6. 6U.O. Radioterapia, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
  7. 7U.O.S. Day Hospital di Oncologia, Università Campus Biomedico, Rome, Italy
  8. 8S.C. Oncologia Medica, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
  9. 9U.O.C. Oncologia, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
  10. 10U.O. Oncologia Medica 1, Policlinico San Martino, Genoa, Italy
  11. 11U.O. Oncologia Medica, IRST, Meldola, Italy
  12. 12U.O. Oncologia Medica, Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Italy
  1. Correspondence to: Andrea Sbrana, U.O. Oncologia Medica 2 Universitaria, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Tel: +39 050992466, e-mail: andreasbrana89{at}gmail.com
View Full Text

Cited By...

  • 3 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (8)
Anticancer Research
Vol. 38, Issue 8
August 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience
ANDREA SBRANA, ELISA BIASCO, FEDERICO PAOLIERI, ERICA PALESANDRO, CLAUDIA CASERTA, ROBERTO IACOVELLI, BEATRICE DETTI, DANIELE SANTINI, ALESSANDRA MOSCA, FRANCO MORELLI, GIUSEPPE FORNARINI, UGO DE GIORGI, CRISTINA MASINI, LUCA GALLI
Anticancer Research Aug 2018, 38 (8) 4913-4918; DOI: 10.21873/anticanres.12807

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience
ANDREA SBRANA, ELISA BIASCO, FEDERICO PAOLIERI, ERICA PALESANDRO, CLAUDIA CASERTA, ROBERTO IACOVELLI, BEATRICE DETTI, DANIELE SANTINI, ALESSANDRA MOSCA, FRANCO MORELLI, GIUSEPPE FORNARINI, UGO DE GIORGI, CRISTINA MASINI, LUCA GALLI
Anticancer Research Aug 2018, 38 (8) 4913-4918; DOI: 10.21873/anticanres.12807
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis
  • Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated Radiotherapy
  • Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
Show more Clinical Studies

Similar Articles

Keywords

  • mRCC
  • pazopanib
  • response
  • first-line
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire